16 July 2024 · Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
15 July 2024 · Informing and supporting decision making when considering the most appropriate legal mechanism for administering contrast agents in imaging services.
19 March 2024 · Delegation of any PGD function is not permitted. However there are specific tasks that individuals other than the professional working under a PGD can fulfil.
6 March 2024 · Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.
6 March 2024 · Two licensed eculizumab biosimilars are available: Bekemv and Epysqli. Learn about the licensed indications, supporting evidence and key differences.
6 March 2024 · Introducing biosimilar eculizumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
5 March 2024 · Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.
5 March 2024 · One licensed tocilizumab biosimilar is available: Tyenne. Learn about the licensed indications, supporting evidence and key differences.
5 March 2024 · Introducing biosimilar tocilizumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.